MS in Regenerative and Stem Cell Technologies
Regenerative and stem cell technologies have the potential to revolutionize treatments for numerous diseases and health conditions. Students in the Master of Science in Regenerative and Stem Cell Technologies program develop the expertise needed to advance in this rapidly growing field. This online program also provides students with an option to collaborate with JHU’s research faculty during a brief lab residency that offers hands-on experience.
The program can be tailored for numerous career goals with electives that span an array of specializations. Specializations include:
-
AI and Automation in Biotechnology
-
Alternative Medical Products in Biotechnology
-
Cancer Biotechnology
-
Finance in Biotechnology
-
Healthcare Biotechnology
-
Industrial Biotechnology
-
Laboratory Medicine
-
Manufacturing and Process Science
-
Medical Device Biotechnology
-
Nanotechnology and Drug Delivery
-
Systems and Integrative Biotechnology
-
Translational Biotechnology
This 10-course degree program offers an option to complete a thesis, is offered part-time or full-time, and can be completed 100% online. Students who choose the one-week lab residency can find the flexibility needed to meet work and life commitments while preparing to advance in this emerging field.
Admissions Criteria for all Advanced Academic Programs
PROGRAM-SPECIFIC REQUIREMENTS
In addition to the materials and credentials required for all programs, the Master of Science in Regenerative and Stem Cell Technologies program requires an undergraduate degree in the sciences or engineering with at least a 3.0 on a 4.0 scale. Meeting the minimum GPA requirement does not guarantee admission.
Resume
Statement of Purpose: Please provide a statement, up to one page in length, describing your personal background and/or a part of your life experience that has shaped you or your goals. Feel free to elaborate on personal challenges and opportunities that have influenced your decision to pursue a graduate degree at Johns Hopkins.
Required Coursework:
- One semester of organic chemistry
- One semester of biochemistry
- One semester of molecular biology
- One semester of cell biology
Program Requirements
Students in the MS in Regenerative and Stem Cell Technologies program must complete:
- Six core courses (five required, one customizable)
- Four electives (i.e., any AS.410.xxx course above AS.410.607 not already taken)
| Code | Title | Credits |
|---|---|---|
| Core Courses - Required: | 20 | |
| Developmental Biology | ||
| Gene Therapy | ||
| Regenerative Medicine: from Bench to Bedside | ||
| Ethics in Emerging Bioscience Technologies | ||
| Stem Cell Biology | ||
| Core Customizable Courses: | 4 | |
| Tissue-Engineered Systems for Drug Discovery and Development | ||
| Manufacturing and Processes for Biotherapeutics | ||
| Stem Cell Culture Laboratory Methods | ||
| Electives | ||
| Select four electives 1 | 16 | |
| Total Credits | 40 | |
- 1
Students may select four electives from the course listings page.
MS in Regenerative and Stem Cell Technologies with Thesis Option
Students interested in pursuing the MS in Regenerative and Stem Cell Technologies with thesis are required to take 11 courses. The thesis requires a two-semester research project. Students will complete AS.410.800 Independent Research in Biotechnology and AS.410.801 Biotechnology Thesis in a subsequent semester. Students interested in this option should consult with their faculty advisor.
Learning Objectives
Graduates of the MS in Regenerative and Stem Cell Technologies program will be equipped to:
- Demonstrate laboratory-based methods to manipulate stem cells
- Assess diverse methods of regenerative and stem cell technologies and their applications
- Analyze the continuum from research-based methods to clinical applications
- Apply current FDA guidance on cell therapy, gene therapy, and tissue engineering to real-world scenarios
- Analyze the early development of complex organisms
- Appraise the ethical reasoning behind the usage of cell therapy, gene therapy, and tissue engineering in patients